EGRX
PINK Eagle Pharmaceuticals, Inc.$0.2100 ↓ -0.7600 (-78.35%) Trading Down from the previous close of $0.9700, $0.7600 below the day’s high of $0.9700
- YTD change
- -64.71%
- vs 20-day SMA
- -66.57%
- vs 200-day SMA
- N/A
Price ranges
Price & Performance
+0.71 (+283.85%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 93.0% away from all-time highs of $3.0000
- EGRX is down 65% since the beginning of the year
- EGRX is down 65% over the past 12 months
- EGRX is down 43% over the past 1 month
- 0% of all EGRX investors are betting against EGRX
EGRX reads poor: the 12-month move is -68.0%.
- Previous minute
- +$0.0000
- Last hour
- -$0.7600
- Last 5 days
- -76.67%
- vs 8-day SMA
- -76.28%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Eagle Pharmaceuticals, Inc. is a biotechnology pharmaceutical company, which focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. Its products include RYANODEX, BENDEKA and BELRAPZO. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.